1 / 25

Status Epilepticus

Status Epilepticus. PICU Resident Lecture Series Lucile Packard Children’s Hospital (Updated: April 2011). Objectives. What are common causes of SE Learn the physiologic sequela of SE (Why do these patients need to be in the PICU?) Learn what tests/labs are needed acutely

gareth
Télécharger la présentation

Status Epilepticus

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Status Epilepticus PICU Resident Lecture Series Lucile Packard Children’s Hospital (Updated: April 2011)

  2. Objectives • What are common causes of SE • Learn the physiologic sequela of SE • (Why do these patients need to be in the PICU?) • Learn what tests/labs are needed acutely • Acute management of SE • Including procedures, medications, and “pentobarb” comas

  3. Definitions • No absolute definition of Status Epilepticus (EP) • Generally accepted definition is • Greater than 30 minutes OR • Frequent seizures without returning to baseline • Treatment if seizure lasts >5 minutes • High risk of lasting >30 minutes • Delayed treatment can lead to permanent sequela

  4. Common etiologies

  5. Common drugs related to seizures • Penicillins • Isoniazid • Metronidazole • Antihistamines • Narcotics • Ketamine • Halothane/Enflurane • Tricyclic antidepressants • Antipsychotics • Phencyclidine • Cocaine

  6. Physiologic Consequences of SE • Phases of SE • Respiratory Effects • Hyperpyrexia • Metabolic derangements • Laboratory changes • Summary

  7. Phases of SE • Hyperdynamic Phase • Increased cerebral metabolic demand • Massive catecholamine/autonomic discharge • Increased CBF, HTN, tachycardia • Exhaustive Phase (with persistent SE) • Catecholamine depletion • Hypotension, decreased CBF • Can lead to neuronal damage (ongoing metabolic demand with tissue hypoxia)

  8. Respiratory Effects • Hypoxia and Hypercarbia are common • Chest wall rigidity (muscle spasms, oral secretions) • Hypermetabolic state with increased 02 demand and increased C02 production • Neurogenic pulmonary edema is rare complication • Marked increased in pulmonary vascular pressure is presumed etiology

  9. Hyperpyrexia • Can lead to seizures or be a result of SE • Exacerbates mismatch of cerebral metabolic demand and substrate delivery • Therefore fevers should be treated aggressively • Antipyretics/cooling

  10. Metabolic derangements • Acidosis • Lactic acidosis due to poor tissues oxygenation with inc energy expenditure • Respiratory acidosis may also develop • Glucose • Initial hyperglycemia from catecholamine surge followed by hypoglycemia • Can be detrimental to the brain, and can further worsen lactic acidosis

  11. Metabolic derangements (cont’d) • Rhabdomyolysis • Protracted tonic-clonic activity can have extensive muscle breakbdown • Leads to hyperkalemia, myoglobinuria • Leukocytosis • Stress response causes demarginalization of SBCs • In 15% of children, this leukocytosis can be seen in the CSF

  12. Summary of complications

  13. Treatment • ABCs • Venous access • Labs • Other diagnostic • Meds

  14. ABCs • Avoid hypoxia by providing oxygen (facemask or NC) • Oral airway can be helpful (but difficult to place) • Nasal trumpet is good alternative • Optimize position, jaw thrust • If poor respiratory effort, begin bag-mask ventilation and consider intubation

  15. Intubation • Some indications: • Difficult to maintain airway • Unable to manage oral secretions • Ineffective respiration • Hypoxia • Hypercarbia • CNS pathology, unequal pupils • SE >30 minutes despite appropriate treatments • REMEMBER: paralytics DO NOT control CNS epileptiform discharges

  16. Venous access • Obtain IV/IO access • Can give IM or Rectal meds but venous access is necessary • Blood pressure management • Hypertension likely to resolve with sz control • Some cases need tx (like inc BP with renal failure) • Start volume resuscitation if hypotensive with bolus of NS (20ml/kg)

  17. Labs required in ALL pts with SE: • CBC, Chem panel (with LFTs, glucose, ca, mg) • Hyponatremia and hypocalcemia are readily treatable • Stat beddside glucose (*especially in neonates and infants) • Ammonia • Anticonvulsant levels • Tox screen • LP: defer in pts with signs of increased ICP or if unstable (but do not delay therapy i.e. abx)

  18. Other diagnostics • CT scan • Focal seizures or deficits; History of trauma • Non-contrast: mass lesions, hemorrhage, hydrocephalus • Contrast: meningitis, abscess, encephalitis • EEG- indicated in ALL pts with SE • Standard: one time study in SE that has resolved • Continuous: difficult to control SE, burst suppresion, subclinical seizures • Video: can be used in conjunction for seizures that are difficult to characterize

  19. Medications • Initiate antiepileptic therapy early • With delayed treatment, pt will also have delayed response to treatment • Thus requiring higher doses • Combine rapid acting to control with long acting to prevent recurrence

  20. Rapid Acting Anticonvulsants

  21. Long Acting Anticonvulsants

  22. Persistent SE • “Pentobarb” coma • CNS electrical quiescence by continuous infusion • Pentobarbital: 1-3mg/kg/hr after bolus (10mg/kg) • Midazolam: 1-10mcg/kg/min after bolus (0.15mg/kg) • Propofol 20-70 mcg/kg/min • Normal physiologic activity also suppressed • Intubation necessary

  23. “Pentobarb” coma (cont’d) • Central line placement • For delivery of continuous infusion • May cause hypotension so pt may require rapid fluid bolus or inotropes • Treat hypotension aggressively in these pts • Continuous EEG • “Burst suppression” is the specific electric pattern noted on EEG once in a successful coma. Electrical activity is only noted once per screen (15-20sec)

  24. “Pentobarb” coma (cont’d) • Pt must be started on a long acting anticonvulsant • Check for therapeutic levels • Burst suppression for 24-48 hrs • Coma gradually lifted while monitoring for seizure activity

  25. Non-convulsive SE • Up to 20% of children with SE have non-convulsive SE after tonic-clonic activity • If no response to painful stimulation within 20-30 min of tonic-clonic activity • Urgent EEG • Must maintain High Index of Suspicion • Often difficult to assess (i.e. previous medications, post-ictal state) • Neurology consult is imperative

More Related